skip to Global Navigation Bar skip to main content

homeHome > About Us > Press Release > News


News Content
Daewoong Pharmaceutical selected for government funding for DWN12088, a new medication for pulmonary fibrosis.
Date 2019-03-08 Hit 489
News List
Prev Daewoong Pharmaceutical exceeds 1 trillion KRW in 2018 to reset the record.
Next Daewoong Pharmaceutical leads innovation of local business by focusing on technology transfer with Trapaco, the largest pharmaceuticals company in Vietnam.